Takashi Yoshinaga
Tsukuba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
In vitro and preclinical assessment of drug interactions between fluoroquinolones and a nonsteroidal antiinflammatory drug predicting risk of seizure.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: March 26, 2026
Author Correction: Diversity-oriented synthesis yields novel multistage antimalarial inhibitors.
Journal: Nature
Published: November 29, 2025
Advanced cardiotoxicity profiling using field potential imaging with UHD-CMOS-MEA in human iPSC-derived cardiomyocytes.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: September 30, 2025
In vitro seizure risk assessment using a microelectrode array and comparison with an in vivo rat study.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: April 24, 2025
Results from an EFPIA, JPMA, PhRMA industry survey on reopening and revamping the ICH S7A guidance on safety and secondary pharmacology.
Journal: Journal of pharmacological and toxicological methods
Published: March 04, 2025
Comparative sensitivity of laboratory animals used for preclinical convulsion risk assessment to drug-induced convulsion.
Journal: The Journal of toxicological sciences
Published: September 04, 2024
Contractility assessment using aligned human iPSC-derived cardiomyocytes.
Journal: Journal of pharmacological and toxicological methods
Published: February 08, 2024
Cardiovascular safety pharmacology: in vitro strategies and improvements in technology and evaluation
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: September 02, 2021
Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
Journal: Clinical and translational science
Published: October 27, 2020
Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective.
Journal: Clinical pharmacology and therapeutics
Published: June 02, 2020
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy.
Journal: Clinical pharmacology and therapeutics
Published: June 24, 2019
Last Updated: 09/26/2026